These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. Bressler SB; Qin H; Melia M; Bressler NM; Beck RW; Chan CK; Grover S; Miller DG; JAMA Ophthalmol; 2013 Aug; 131(8):1033-40. PubMed ID: 23807371 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585 [TBL] [Abstract][Full Text] [Related]
9. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Mitchell P; Bandello F; Schmidt-Erfurth U; Lang GE; Massin P; Schlingemann RO; Sutter F; Simader C; Burian G; Gerstner O; Weichselberger A; Ophthalmology; 2011 Apr; 118(4):615-25. PubMed ID: 21459215 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema. Faghihi H; Roohipoor R; Mohammadi SF; Hojat-Jalali K; Mirshahi A; Lashay A; Piri N; Faghihi Sh Eur J Ophthalmol; 2008; 18(6):941-8. PubMed ID: 18988166 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479 [TBL] [Abstract][Full Text] [Related]
12. Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. ; Googe J; Brucker AJ; Bressler NM; Qin H; Aiello LP; Antoszyk A; Beck RW; Bressler SB; Ferris FL; Glassman AR; Marcus D; Stockdale CR Retina; 2011 Jun; 31(6):1009-27. PubMed ID: 21394052 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study. ; Chew E; Strauber S; Beck R; Aiello LP; Antoszyk A; Bressler N; Browning D; Danis R; Fan J; Flaxel C; Friedman S; Glassman A; Kollman C; Lazarus H Ophthalmology; 2007 Jun; 114(6):1190-6. PubMed ID: 17544778 [TBL] [Abstract][Full Text] [Related]
14. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema. Mukkamala L; Bhagat N; Zarbin MA Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Dewan V; Lambert D; Edler J; Kymes S; Apte RS Ophthalmology; 2012 Aug; 119(8):1679-84. PubMed ID: 22503301 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial. Gillies MC; McAllister IL; Zhu M; Wong W; Louis D; Arnold JJ; Wong TY Invest Ophthalmol Vis Sci; 2010 May; 51(5):2322-8. PubMed ID: 20019369 [TBL] [Abstract][Full Text] [Related]
17. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244 [TBL] [Abstract][Full Text] [Related]
18. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. ; Beck RW; Edwards AR; Aiello LP; Bressler NM; Ferris F; Glassman AR; Hartnett E; Ip MS; Kim JE; Kollman C Arch Ophthalmol; 2009 Mar; 127(3):245-51. PubMed ID: 19273785 [TBL] [Abstract][Full Text] [Related]
19. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. ; ; Aiello LP; Beck RW; Bressler NM; Browning DJ; Chalam KV; Davis M; Ferris FL; Glassman AR; Maturi RK; Stockdale CR; Topping TM Ophthalmology; 2011 Dec; 118(12):e5-14. PubMed ID: 22136692 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Sutter FK; Simpson JM; Gillies MC Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]